4106 Stock Overview
Provides medical solutions for healthcare professionals worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Wellell Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$24.65 |
| 52 Week High | NT$30.60 |
| 52 Week Low | NT$24.20 |
| Beta | 0.22 |
| 11 Month Change | -3.14% |
| 3 Month Change | -4.83% |
| 1 Year Change | -12.59% |
| 33 Year Change | -11.65% |
| 5 Year Change | -1.79% |
| Change since IPO | 56.64% |
Recent News & Updates
Recent updates
Wellell's (TWSE:4106) Dividend Is Being Reduced To NT$0.80
Jul 22
Wellell (TWSE:4106) Has Announced That Its Dividend Will Be Reduced To NT$0.80
Jul 04Some May Be Optimistic About Wellell's (TWSE:4106) Earnings
Mar 23Should You Or Shouldn't You: A Dividend Analysis on Apex Medical Corp. (TPE:4106)
Mar 29Reflecting on Apex Medical's (TPE:4106) Share Price Returns Over The Last Five Years
Mar 01Returns On Capital At Apex Medical (TPE:4106) Paint An Interesting Picture
Feb 11
Weak Financial Prospects Seem To Be Dragging Down Apex Medical Corp. (TPE:4106) Stock
Jan 27Is Apex Medical (TPE:4106) Using Too Much Debt?
Jan 12Is Apex Medical Corp. (TPE:4106) A Good Fit For Your Dividend Portfolio?
Dec 28Does Apex Medical's (TPE:4106) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 13Apex Medical (TPE:4106) Share Prices Have Dropped 28% In The Last Five Years
Nov 27Shareholder Returns
| 4106 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -0.2% | -2.8% | -4.2% |
| 1Y | -12.6% | 1.0% | 28.9% |
Return vs Industry: 4106 underperformed the TW Medical Equipment industry which returned 1% over the past year.
Return vs Market: 4106 underperformed the TW Market which returned 28.9% over the past year.
Price Volatility
| 4106 volatility | |
|---|---|
| 4106 Average Weekly Movement | 1.6% |
| Medical Equipment Industry Average Movement | 3.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4106 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4106's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | n/a | Daniel Lee | www.wellell.com/en |
Wellell Inc. provides medical solutions for healthcare professionals worldwide. The company offers wound management products, including Serene Air and Serene Elite, which are alternating pressure redistribution systems for patients with high to very high risk for pressure ulcers; ACS Turn, a low air lateral turning mattress; Pro-care Optima, an alternating pressure redistribution system for patients with high to very high risk of pressure injuries; Pro-care turn, a bilateral turning air mattress for patients with medium to high risk of pressure injuries; Domus Auto, Domus 4, and Verso for patients with medium to high risk of pressure injury; Domus 3 for patients with medium risk of pressure injury; Domus 2s for patients with low to medium risk of pressure injury; Domus 1 for patients in low risk of pressure injury; Sedens 500 and Sedens 400, which are seat cushions; and Flexi-Air, a non-powered hybrid mattress. It also provides respiratory therapy products, such as nasal masks, full face masks, nasal pillows mask, portable suction unit, and compressor nebulizers; iCH Auto and XT Auto for automatic positive airway pressure; XT Prime, XT Sense, and XT Fit for continuous positive airway pressure; XT Heated Humidifier for humidification; and medical equipment.
Wellell Inc. Fundamentals Summary
| 4106 fundamental statistics | |
|---|---|
| Market cap | NT$2.48b |
| Earnings (TTM) | NT$95.66m |
| Revenue (TTM) | NT$2.45b |
26.0x
P/E Ratio1.0x
P/S RatioIs 4106 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4106 income statement (TTM) | |
|---|---|
| Revenue | NT$2.45b |
| Cost of Revenue | NT$1.35b |
| Gross Profit | NT$1.10b |
| Other Expenses | NT$1.00b |
| Earnings | NT$95.66m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.95 |
| Gross Margin | 44.88% |
| Net Profit Margin | 3.90% |
| Debt/Equity Ratio | 14.1% |
How did 4106 perform over the long term?
See historical performance and comparison